Cause Of Common Chronic Diarrhea Revealed In New Research, Imperial College London, King's College London, and University of Edinburgh Study 11/6/2009
More...
|
Budesonide is Not Beneficial for the Treatment of Diarrhea in Metastatic Melanoma Patients Receiving Ipilimumab, H. Lee Moffitt Cancer Center & Research Institute Study 8/12/2009
More...
|
Kefir, Although Rich in Probiotics, Did Not Prevent Diarrhea in Children Using Antibiotics, Georgetown University Medical Center Researchers Say 8/4/2009
More...
|
New Trial Casts Doubt On Role Of Zinc Supplements In Diarrhea Treatment, Lata Medical Research Foundation Study 5/11/2009
More...
|
Seegene, Inc. Introduces Diagnostic Test for Diarrhea 4/29/2009
More...
|
Vaccine For Traveler's Diarrhea May Be Within Reach, Naval Medical Research Center Study 4/17/2009
More...
|
Medarex, Inc. (MEDX) and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea 11/3/2008
More...
|
New Optimer Pharmaceuticals, Inc. Drug Treats Traveler's Diarrhea, University of Texas Study 10/29/2008
More...
|
Merck & Co., Inc. (MRK)Vaccine Slashes Diarrheal Illness In Kids, Centers for Disease Control and Prevention (CDC) Says 10/27/2008
More...
|
Optimer Pharmaceuticals, Inc. Completes Enrollment in Second Prulifloxacin Phase 3 Clinical Trial 9/2/2008
More...
|
Endobiologics Corporation and PATH Form New Collaboration to Research Vaccine Candidates Against Diarrheal Disease 8/19/2008
More...
|
Optimer Pharmaceuticals, Inc. (JOBS) Announces Positive Results in Prulifloxacin Phase 3 Study 7/16/2008
More...
|
Patch Vaccine Holds Off Traveller's Diarrhea: University of Texas Study 6/12/2008
More...
|
IOMAI Corporation (IOMI) Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6/12/2008
More...
|
Optimer Pharmaceuticals, Inc. Receives Polymorph Patent for Lead Product Candidate OPT-80 5/27/2008
More...
|
Optimer Pharmaceuticals, Inc. Release: Clostridium difficile Infection 'Epidemic' Leads to Calls for Emerging Next-Generation Therapies 4/21/2008
More...
|
Roche (RHHBY) and the Institute for OneWorld Health Announce Research Collaboration to Fight Neglected Diarrheal Diseases in Developing Countries 4/17/2008
More...
|
Optimer Pharmaceuticals, Inc. Sponsors ECCMID Symposium on Clostridium Difficile-Associated Disease: Current Treatments and Challenges 4/15/2008
More...
|
Napo Pharmaceuticals, Inc. Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 4/11/2008
More...
|
Optimer Pharmaceuticals, Inc. Announces Peer-Reviewed Publication of OPT-80 Phase 1 Clinical Results for the Treatment of Clostridium Difficile Infection 4/2/2008
More...
|
Optimer Pharmaceuticals, Inc. Completes Enrollment in Phase 3 Clinical Trial of Prulifloxacin in Patients with Travelers' Diarrhea 3/11/2008
More...
|
Anadis Limited (ANX.AX) Launches Products to Reduce Global Childhood Diarrhea Deaths - Oral Rotavirus & E.coli Antibodies 3/10/2008
More...
|
IOMAI Corporation (IOMI) Study Shows Self-Applied Travelers' Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch 2/12/2008
More...
|
AGI Therapeutics plc Announces First Patient Dosed in Phase II Trial of AGI-004 in Chemotherapy-induced Diarrhoea
2/5/2008
More...
|
Small Pet Turtles Cause Salmonella Outbreak 1/25/2008
More...
|
Glenmark Pharmaceuticals Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea 12/6/2007
More...
|
Giardia Loses its Hold on Intestinal Tissue after 'Tonic Shock' 12/4/2007
More...
|
Tranzyme Pharma's Motilin Antagonist TZP-201 Shows Potential for Preventing and Treating Chemotherapy-Induced Diarrhea (CID) 10/24/2007
More...
|
IOMAI Corporation (IOMI) Patch-Based Vaccine Cut Rate of Travelers' Diarrhea by 75 Percent in Phase 2 Field Study 9/19/2007
More...
|
FDA Has Approved Zealand Pharma 's Investigative New Drug Application (IND) for ZP1846 to Be Administered in Humans; ZP1846 Is Developed for the Prevention and Treatment of Severe Diarrhoea Induced by Chemotherapy 9/6/2007
More...
|
IOMAI Corporation (IOMI) Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentation at ICAAC 8/23/2007
More...
|
Despite Claims, Not All Probiotics Can Treat Diarrhea Say Experts 8/10/2007
More...
|
IOMAI Corporation (IOMI) Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine 8/9/2007
More...
|
IOMAI Corporation (IOMI) to Announce Positive Results from Phase 2 Field Trial of Its Travelers Diarrhea Vaccine 8/1/2007
More...
|
Genzyme Corporation (GENZ)'s Diarrhea Drug Tolevamer Fails Phase 3 Trial 7/6/2007
More...
|
Cosmo Pharmaceuticals S.p.A.'s Rifamycin Meets Target in Diarrhea Trial 7/5/2007
More...
|
Napo Pharmaceuticals, Inc. Obtains IRB Approval for Phase 3 Clinical Trial Protocol for Crofelemer In HIV/AIDS Diarrhea Assessment 3/14/2007
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Returns Diarrhea Drug Marketing Rights to Optimer Pharmaceuticals, Inc.; Par to Receive $25 Million in Payments 2/27/2007
More...
|
Zithromax Effective For Traveler's Diarrhea 2/14/2007
More...
|
Napo Pharmaceuticals, Inc. Completes Feasibility Assessment For Chronic Diarrhoea In People Living With HIV/AIDS (CRO-HIV) 12/20/2006
More...
|
Napo Pharmaceuticals, Inc. Announces The Successful Production Of Crofelemer Active Pharmaceutical Ingredient 11/17/2006
More...
|
Gates Foundation Helping Diarrhea Research; $46 Million Grant To Institute for OneWorld Health 11/1/2006
More...
|
Cruise Illness May Be Common Virus 10/23/2006
More...
|
Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories Announce Commencement Of Phase II Clinical Trial Of Anti-C. difficile Antibody Combination For The Treatment Of Hospital Acquired Diarrhea 9/6/2006
More...
|
Galapagos Genomics NV And Oneworld Health Collaborate To Develop New Drugs For The Treatment Of Diarrheal Diseases 9/6/2006
More...
|
IOMAI Corporation (IOMI) Launches Phase 2 Clinical Study Of Vaccine Patch For Travelers' Diarrhea 8/15/2006
More...
|
Goat Milk Engineered To Mimic Mother's 8/4/2006
More...
|
Napo Pharmaceuticals, Inc. Receives Approval From Indian Regulator To Initiate Phase II Clinical Trial For Crofelemer For Acute Infectious Diarrhea In Adult Patients 8/3/2006
More...
|
University of California, Los Angeles (UCLA) Researchers Discover New Disorder That Causes Chronic Diarrhea In Children 7/20/2006
More...
|
Diarrhea Treatment Grown In Transgenic Rice Raises Uproar In Peru 7/14/2006
More...
|
Worms May Help Bowel Disease 6/12/2006
More...
|
World Cup: Blisters From New Football Boots Linked To Toxic Shock Syndrome 6/8/2006
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Reports Digestive Disease Week 2006 Update 5/22/2006
More...
|
Travellers' Diarrhoea Vaccines – A Good Run For Your Money? 5/18/2006
More...
|
IOMAI Corporation (IOMI) To Present Data From Flu And Traveler's Diarrhea Programs 5/10/2006
More...
|
IOMAI Corporation (IOMI) Shows Dry Vaccine Patch Is Effective 4/6/2006
More...
|
Optimer Pharmaceuticals, Inc.'s Lead Antibiotic Candidate Moves Into Phase 2B/3 Clinical Trials For The Treatment Of Clostridium Difficile-Associated Diarrhea (CDAD) 2/7/2006
More...
|
FDA Approves Merck & Co., Inc. (MRK)'s ROTATEQ(R), The Only Vaccine In The U.S. To Prevent Rotavirus Gastroenteritis 2/6/2006
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Completion Of First XIFAXAN(R) Travelers' Diarrhea Prevention Study 1/4/2006
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Agrees With FDA On Steps For Ramoplanin 12/21/2005
More...
|
Heartburn Drugs Linked To Diarrhea 12/20/2005
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Release: New Antibiotic Candidate Shows Promise In Treating Clostridium Difficile-Associated Diarrhea (CDAD) 12/19/2005
More...
|
FDA Staff Seek More Information On Merck & Co., Inc. (MRK) Rotavirus Vaccine 12/13/2005
More...
|
Zinc Supplements Help HIV-Infected Children 11/28/2005
More...
|
Dynogen Pharmaceuticals, Inc. Initiates Phase II Trial Of DDP225 For Treatment Of Patients With Diarrhea-Predominant Irritable Bowel Syndrome 10/17/2005
More...
|
Osel, Inc. Begins Phase 2/3 Clinical Study For Prevention Of AAD 10/11/2005
More...
|
Massachusetts Biologic Laboratories And Medarex, Inc. (MEDX) Announce Commencement Of Phase II Clinical Trial Of A Fully Human Antibody For The Treatment Of Hospital Acquired Diarrhea 10/11/2005
More...
|
Dark Chocolate Helps Diarrhea 9/30/2005
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Publication Of Study Results Suggesting XIFAXAN(TM) Potential In Treatment Of Active Crohn's Disease 8/11/2005
More...
|
Napo Pharmaceuticals, Inc. Adds Glenmark Pharmaceuticals Of India To Global Team To Develop And Commercialize A Novel Treatment For Diarrhea 7/7/2005
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Moves Forward With XIFAXAN Travelers' Diarrhea Prevention Study; First Step Toward XIFAXAN Filing For Prophylactic Indication 7/6/2005
More...
|
Dowpharma(SM) Announces Commercial License Agreement For Pfenex Expression Technology(TM) With Iomai Corporation 6/24/2005
More...
|
Chinese Medicine Kills One Child, Makes 151 Sick 6/21/2005
More...
|
Napo Pharmaceuticals Signs Development, Commercialization Alliance With AsiaPharm Of China 6/16/2005
More...
|
Depomed, Inc. (DEPO) Receives FDA Approval Of Proquin XR For Uncomplicated Urinary Tract Infections; "Uncommon" Adverse Events In Its Label 5/20/2005
More...
|
Rifaximin Is Effective In Preventing Attacks Of Diarrhea 5/17/2005
More...
|
Louisiana State University Health Sciences Center Release: Once-Monthly Somatostatin Analogue Increases Overall Survival In Carcinoid Syndrome 5/16/2005
More...
|
Genzyme Corporation (GENZ) Announces Start Of Phase 3 Study Of Novel, Non-Antibiotic Therapy For C. difficile Associated Diarrhea 4/4/2005
More...
|
FDA Requests Further Data On Cilansetron, Solvay Pharmaceuticals, Inc.'s Proposed Treatment For Irritable Bowel Syndrome Wth Diarrhea Predominance (IBS-D) 4/1/2005
More...
|
Intercell AG Is Listed On The Vienna Stock Exchange 3/10/2005
More...
|
Medicines Made From Cow Urine And Dung 3/2/2005
More...
|
Osel, Inc. In-licenses Therapeutic Drug Product From Japan 3/2/2005
More...
|
Vela Pharmaceuticals Inc. Announces Positive Phase 2 Results For Dextofisopam In Treating Irritable Bowel Syndrome-- IBS; Results Show Effects Of Dextofisopam Both In Women And In Men 1/6/2005
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Positive Results Of Rifaximin Study; XIFAXAN Study Suggests Potential Use In The Prevention Of Shigellosis 11/9/2004
More...
|
Diarrheal Disease Vaccine Shows Promise 11/1/2004
More...
|
Solvay Pharmaceuticals, Inc. Cilansetron Improves Health Related Quality Of Life In Multinational Phase III Clinical Trial Patients With Irritable Bowel Syndrome With Diarrhea Predominance (IBS-D) 11/1/2004
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Positive Results Of Balsalazide Study; Study Receives ASTRO Resident Clinical Research Award 10/13/2004
More...
|
Active Pass Pharmaceuticals Receives $3.6 Million CDN Grant From NIH For Development Of Novel Treatment For Secretory Diarrhea 10/1/2004
More...
|
Massachusetts Biologic Laboratories And Medarex, Inc. (MEDX) Announce Phase I Clinical Trial Of A Novel Fully Human Antibody For The Treatment Of Hospital Acquired Diarrhea 9/29/2004
More...
|
Solvay Pharmaceuticals, Inc. Release: Cilansetron NDA Filing Accepted For Priority Review By The FDA For The Treatment Of Irritable Bowel Syndrome With Diarrhea Predominance 9/1/2004
More...
|
Study Could Bring Diarrhea Vaccine Closer 8/26/2004
More...
|
Structural Study Of Rotavirus Could Bring Diarrhoea Vaccine Closer 8/25/2004
More...
|
Oscient Pharmaceuticals Corporation (OSCI) Releases Preliminary Results From Phase II Ramoplanin Trial For C. difficile-Associated Diarrhea 8/11/2004
More...
|
Romark Laboratories, L.C. Announces FDA Approval Of Alinia(R) Tablets For Adults 7/22/2004
More...
|
GlaxoSmithKline (GSK) Release: Lower Frequency Of Moderate To Severe Drug-Related Diarrhea Associated With LEXIVA Compared To Nelfinavir In Treatment-Naive HIV Infected Adults 7/14/2004
More...
|
Oscient Pharmaceuticals Corporation Completes Enrollment In Phase II Trial Of Ramoplanin For Clostridium Difficile-Associated Diarrhea; Phase III Program Expected To Begin By Year End 6/21/2004
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Release: FDA Grants Marketing Approval For XIFAXAN -Rifaximin-; First Nonsystemic, Gastrointestinal Selective Antibiotic 5/26/2004
More...
|
Optimer Pharmaceuticals, Inc. Assembles Premier Medical Advisory Board For Company's Lead Antibiotic Drug 5/24/2004
More...
|
Genzyme Corporation (GENZ) Presents Results From Phase 2 C. difficile Clinical Trial - Plans To Advance Program To Phase 3 5/3/2004
More...
|
FDA Issues Warning About IBS Drug Zelnorm 4/29/2004
More...
|
Hope Raised For Diarrhea Vaccine 3/8/2004
More...
|
Gluten Intolerance Linked To Schizophrenia 2/20/2004
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Receives FDA Notification That Rifaximin Amendment Considered A Complete Response 12/10/2003
More...
|
Mast Cells Linked To Allergic Diarrhea 12/5/2003
More...
|